Catalytic investments to accelerate disease elimination in the Americas: This is the moment to act!

Catalytic investments to accelerate disease elimination in the Americas: This is the moment to act!
Catalytic investments to accelerate disease elimination in the Americas    “This is the moment to act!”

The Americas are at a critical moment to accelerate disease elimination. Through PAHO’s Disease Elimination Initiative, countries across the Region are demonstrating strong political and technical commitment, translating this commitment into concrete action and measurable progress. This momentum presents a unique opportunity to build on country leadership through national and catalytic investments, innovation, technical cooperation, and strategic partnerships. This session is a call to governments, partners, and donors to act now—investing in country-led efforts to accelerate progress, achieve new elimination milestones, and sustain the gains already made across the Region.

Objectives

· Highlight why this is a critical moment to accelerate disease elimination in the Americas.

· Showcase country-led approaches that are delivering measurable results.

· Position disease elimination as a high-impact investment opportunity.

· Foster dialogue on partnerships and catalytic investments.

 

 

Details

Date: 30 September 2026 
Time: 12:30 p.m. to 2:00 p.m. 
Venue: Conference Room B, Pan American Health Organization Headquarters, Washington, D.C. 
Live stream: PAHO TV
In-person participation only
 

For other cities, check the corresponding local time here. 

 

Agenda 

Opening remarks

Dr. Jarbas Barbosa, Director, Pan American Health Organization

Panel discussion
From commitment to results: Country experiences accelerating disease elimination

Panelists:
- Peru
- Colombia
- The Bahamas
 

 

Strategic partner perspectives
A call for catalytic investment

- Spanish Agency for International Development Cooperation (AECID)
- Global Affairs Canada
- Gates Foundation
- Unitaid
- U.S. Centers for Disease Control and Prevention (CDC)
 

 

Concluding remarks

Dr. Rhonda Sealey-Thomas, Assistant Director, Pan American Health Organization

Joint agreement signing ceremony

Pan American Health Organization, Bruyère Health Research Institute, and MSD